Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,919
Closed -$14.4K 2827
2024
Q3
$14.4K Hold
16,919
﹤0.01% 2539
2024
Q2
$11.3K Buy
16,919
+1,500
+10% +$1.25K ﹤0.01% 2603
2024
Q1
$20K Hold
15,419
﹤0.01% 2431
2023
Q4
$8.83K Buy
15,419
+2,500
+19% +$1.73K ﹤0.01% 2259
2023
Q3
$9.74K Sell
12,919
-1
-0% -$1 ﹤0.01% 2098
2023
Q2
$9.43K Buy
12,920
+2,000
+18% +$1.86K ﹤0.01% 2091
2023
Q1
$8.26K Sell
10,920
-12,881
-54% -$12K ﹤0.01% 2036
2022
Q4
$22.9K Buy
23,801
+2,465
+12% +$3.48K ﹤0.01% 2214
2022
Q3
$47K Buy
+21,336
New +$73.6K ﹤0.01% 2033

Other funds holding VXRT

Kestra Advisory Services's VXRT Position: Q4 2024 in Review

Kestra Advisory Services sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 16,919 shares — an estimated $14.4K sold.

Kestra Advisory Services first reported a position in VXRT in Q3 2022 and held it in 9 quarters. The position peaked at $47K in Q3 2022. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

  • Kestra Advisory Services reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 16,919 Vaxart shares in Q4 2024, an estimated $14.4K.
  • Kestra Advisory Services first reported a position in Vaxart in Q3 2022 and held it in 9 quarters.
  • Kestra Advisory Services's Vaxart position peaked at $47K in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on Kestra Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.